🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the pharmacodynamic (PD) e...
Status
Completed
Location
Biotrial Inc
Start Date
2018-01-24
Trial ID
NCT03430661
Treatments Being Tested
This is a randomized study of the safety and tolerability of multiple doses...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT01011959
Treatments Being Tested
The purpose of this study was to evaluate the safety and tolerability of iv...
Status
Completed
Location
University of Alabama Hospital
Start Date
2007-05
Trial ID
NCT00457821
Treatments Being Tested
The purpose of this study is to test the safety, tolerability and pharmacok...
Status
Terminated
Location
Hadassah Clinical Research Center (HCRC)
Start Date
2011-06
Trial ID
NCT01121380
The purpose of this study is to evaluate the safety and immunogenicity of H...
Status
Completed
Location
Alabama CRS
Start Date
2020-01-13
Trial ID
NCT04177355
The study will consist of three parts: a single-dose ascending (SAD) phase ...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2023-03-21
Trial ID
NCT05650528
Treatments Being Tested
A randomized, double-blind, placebo-controlled, multiple-dose clinical tria...
Status
Completed
Location
Seoul-National University Hospital
Start Date
2022-01-10
Trial ID
NCT06508645
Treatments Being Tested
This 5-part study will evaluate the safety, tolerability, and pharmacokinet...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00990821
The overall study design includes two parts, Part A and Part B. Part A eva...
Status
Completed
Location
Academisch Medisch Centrum (AMC)
Start Date
2008-06
Trial ID
NCT01211626
This study consists of 3 parts: Part A, Part B and Part C. This study will ...
Status
Completed
Location
Research Site
Start Date
2024-07-15
Trial ID
NCT06491550